Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Gross Margin (2016 - 2025)

Historic Gross Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 56.38%.

  • Angiodynamics' Gross Margin rose 16000.0% to 56.38% in Q4 2025 from the same period last year, while for Nov 2025 it was 54.58%, marking a year-over-year increase of 18700.0%. This contributed to the annual value of 53.92% for FY2025, which is 30100.0% up from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Gross Margin is 56.38%, which was up 16000.0% from 55.29% recorded in Q3 2025.
  • Angiodynamics' Gross Margin's 5-year high stood at 56.38% during Q4 2025, with a 5-year trough of 47.7% in Q1 2024.
  • In the last 5 years, Angiodynamics' Gross Margin had a median value of 52.72% in 2022 and averaged 52.79%.
  • In the last 5 years, Angiodynamics' Gross Margin plummeted by -36200bps in 2021 and then soared by 62700bps in 2025.
  • Over the past 5 years, Angiodynamics' Gross Margin (Quarter) stood at 51.81% in 2021, then grew by 2bps to 52.77% in 2022, then decreased by -4bps to 50.92% in 2023, then grew by 8bps to 54.78% in 2024, then increased by 3bps to 56.38% in 2025.
  • Its Gross Margin stands at 56.38% for Q4 2025, versus 55.29% for Q3 2025 and 52.67% for Q2 2025.